GlassScriptPhysician profile
Quinn T Lichfield
NPI 1770557357
$8,652.76
in general payments reported to CMS, 2019-2025
46 companies · $1,752 in 2025
The $1,752 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $670 · 2021: $1,208 · 2022: $1,127 · 2023: $1,336 · 2024: $1,541 · 2025: $1,752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,628.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,787.40 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,041.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $1,012.43 | 2021-2025 | |
| Novo Nordisk INC | $875.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $673.13 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $533.41 | 2021-2025 | |
| Exact Sciences Corporation | $388.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $313.43 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $304.21 | 2019-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $236.60 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Grifols USA, LLC | $197.46 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $107.15 | 2019-2025 | Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $100.28 | 2022-2023 | |
| Allergan, INC. | $69.25 | 2020 | |
| Cranial Technologies, INC | $66.98 | 2021-2025 | Doc Band |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quinn Lichfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.